← All organizations
Highest phase reached
Phase 4
First clinical trial
Jun 1, 2001Last known activity
Apr 12, 2024
Timeline
1980s
- Jan 1, 1986
Spanish National Health System— Founded
Drugs by trial phase (21 distinct, 16 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (8 own, 0 via acquisition)
Phase 2 (7 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
- Amyotrophic Lateral Sclerosis
- Anemia
- Coinfection
- Diabetic Angiopathies
- Diabetic Foot
- Foot Ulcer
- Glioma
- Leukopenia
- Lymphoma
- Lymphoma, Follicular
- Lymphoma, Non-Hodgkin
- Motor Neuron Disease
- Multiple Organ Failure
- Osteonecrosis
- Osteoporosis
- Retinitis
- Retinitis Pigmentosa
- Sclerosis
- Shock
- Spinal Fractures
- Stroke
- Thrombocytopenia
- Ulcer
Recent trials (16)
- NCT06364631CollaboratorPhase 3Apr 12, 2024
- NCT03570450CollaboratorPhase 1Jun 2, 2018
- NCT02849613CollaboratorPhase 2/Phase 3Mar 31, 2016
- NCT02566681CollaboratorPhase 1Sep 1, 2015
- NCT02566655CollaboratorPhase 1Sep 1, 2015
- NCT02286011CollaboratorPhase 1Nov 1, 2014
- NCT02280135CollaboratorPhase 1Nov 1, 2014
- NCT03311178Overall official - principal investigatorPhase 1/Phase 2May 30, 2014
- NCT02045745CollaboratorPhase 1/Phase 2Dec 1, 2013
- NCT02104440CollaboratorPhase 2Oct 1, 2013
- NCT01529073CollaboratorPhase 2Feb 1, 2012
- NCT01329354CollaboratorPhase 2Mar 1, 2011
- NCT01367223CollaboratorPhase 4Apr 1, 2010
- NCT01574092CollaboratorPhase 2Nov 1, 2009
- NCT01157013CollaboratorN/AJan 31, 2009
Details
- Founded
- Madrid, US Jan 1, 1986
- Last known activity
- Apr 12, 2024